Results 21 to 30 of about 1,152,205 (156)

CKM Gene rs8111989 Polymorphism and Power Athlete Status. [PDF]

open access: yes, 2021
Multiple genetic variants are known to influence athletic performance. These include polymorphisms of the muscle-specific creatine kinase (CKM) gene, which have been associated with endurance and/or power phenotypes.
Utkus, Algirdas,   +39 more
core   +2 more sources

The CKM lattice working group initiative

open access: yes, 2003
We present the CKM-LWG, a collection of working groups whose aim is to compile world averages of lattice results relevant for high-energy ...
Flynn, Jonathan   +3 more
core   +1 more source

Overall Sleep Quality Is Associated With Advanced Stages in Patients With Cardiovascular–Kidney–Metabolic Syndrome

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background In 2023, the American Heart Association defined the concept of cardiovascular–kidney–metabolic (CKM) syndrome as a health disorder ascribed to connections among obesity, diabetes, chronic kidney disease, and cardiovascular disease.
Dingyuan Tu   +4 more
doaj   +1 more source

Correlation between triglyceride glucose-waist-to-height ratio and advanced cardiovascular-kidney-metabolic syndrome

open access: yesZhongguo Linchuang Yixue
ObjectiveTo explore the correlation between the triglyceride glucose-waist-to-height ratio (TyG-WHtR) and advanced cardiovascular-kidney-metabolic (CKM) syndrome.
Xingxing REN
doaj   +1 more source

Cardiovascular-kidney-metabolic syndrome, systemic inflammation, and incident dementia: evidence from 400,740 UK Biobank participants

open access: yesDiabetology & Metabolic Syndrome
Background Although some studies examined the association of individual risk factors for cardiovascular-kidney-metabolic (CKM) syndrome (diabetes, chronic kidney disease, and stroke) with the risk of incident dementia, little is known about the impact of
Pingan Li   +10 more
doaj   +1 more source

Chinese Expert Consensus on the Clinical Application of Finerenone in Geriatric Comorbidities

open access: yesAGING MEDICINE, EarlyView.
Mineralocorticoid receptor (MR) overactivation drives inflammation, oxidative stress, and fibrosis in the heart, kidneys, and vasculature, leading to cardiorenal dysfunction. MR signaling promotes hypertrophy, remodeling, and injury through pathways like oxidative stress and inflammation, resulting in vascular stiffness and progressive organ damage ...
Xiaoming Wang, Cuntai Zhang
wiley   +1 more source

Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Hypertension in obesity represents a major global health challenge, closely linked to the global epidemics of obesity, type 2 diabetes and metabolic dysfunction. Excess adiposity contributes to elevated blood pressure through multiple, interrelated mechanisms, including activation of the renin–angiotensin–aldosterone system, sympathetic nervous system ...
Christina Antza   +12 more
wiley   +1 more source

Association between dietary inflammatory index score and cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES

open access: yesFrontiers in Nutrition
BackgroundCardiovascular-kidney-metabolic (CKM) syndrome affects 25% of US adults, with chronic inflammation as a key pathophysiological mechanism. While the inflammatory basis of CKM syndrome is established, associations of the energy-adjusted dietary ...
Huang Yu   +4 more
doaj   +1 more source

Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Chiara Benedetto   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy